Blog

Home » Blog

Evidence says less may be more when it comes to radiation for bone metastases

Patients enduring the excruciating pain of cancer that has spread to the bones are often given multiple doses of radiation. There is strong evidence, however, that one dose controls pain as effectively as 10 or more. In addition, one treatment is cheaper and far more convenient for patients who already have plenty on their minds. Read the Article.

Evidence says less may be more when it comes to radiation for bone metastases Read More »

VIDEO: Dr. Danny Vesprini, “Prostate Cancer – identifying men at high risk before it’s too late”

September 2013 Scotiabank Awareness Night “Prostate Cancer – identifying men at high risk before it’s too late” Dr. Danny Vesprini,   MD, MSc, BSc, FRCPC Assistant Professor  Department of Radiation Oncology, University of Toronto  Staff Radiation Oncologist, Sunnybrook Odette Cancer Centre Dr. Vesprini discusses the current and upcoming strategies for screening and ultimately treating men who are at increased risk of developing aggressive prostate cancer, including men with a strong family history, men with a known genetic trait that causes aggressive disease, and men of Western African/Caribbean descent. CLICK ON THE ARROW TO START THE VIDEO Click here for Complete Video  Introduction by

VIDEO: Dr. Danny Vesprini, “Prostate Cancer – identifying men at high risk before it’s too late” Read More »

Focal Therapy – New pain-free treatment for prostate cancer? Not quite

If you or someone close to you has lived with prostate cancer, you’ve probably come across dozens of emerging treatments in your hours of Googling. One such treatment, focal therapy, has been dubbed the “new pain-free treatment for prostate cancer”. But don’t hold your breath; it’s still in its experimental phases. This is a warning that focal therapy is still experimental and should be considered only in a clinical trial setting.  Read the article.

Focal Therapy – New pain-free treatment for prostate cancer? Not quite Read More »

New Urine Test for Prostate Cancer – More Specific

Prostate Cancer Foundation Announces New Urine Test for Prostate Cancer Available; Unlike PSA Test, is Ultra Specific for Prostate Cancer A new urine test for prostate cancer that measures minute fragments of RNA is now commercially available to men nationwide through the University of Michigan MLabs. The new test—Mi-Prostate Score (MiPS)—improves the utility of the PSA blood test, increases physicians’ ability to pick out high-risk prostate tumors from low-risk tumors in patients, and may help tens of thousands of men avoid unnecessary biopsies. Read the article.

New Urine Test for Prostate Cancer – More Specific Read More »

Living Longer and Healthier with Prostate Cancer

If you’re living with prostate cancer, you may be able to live longer and healthier by making some changes to your eating and exercise routine. Increasingly, studies show that healthy eating and maintaining an active lifestyle after a prostate cancer diagnosis can lower the chances of the cancer coming back, and can improve the chances of staying disease-free. Healthy habits, such as not smoking, can also improve survival. Benefits may also include a lowered risk of heart disease. Read the Article.

Living Longer and Healthier with Prostate Cancer Read More »

Researchers Discover Prostate Cancer-Fighting Compound in Jamaican Allspice

Essential to jerk seasoning, allspice is known for flavoring Jamaican and other cuisines around the world with a blend of cinnamon, cloves, nutmeg and pepper but, according to a new study by Miller School researchers, the aromatic spice could be known one day for impeding the growth of, or maybe even preventing, prostate cancer, the No. 2 cancer-killer of men in the U.S. Read the article.

Researchers Discover Prostate Cancer-Fighting Compound in Jamaican Allspice Read More »

PCC Releases New Recommmendations on PSA Testing

Sept. 5, 2013 PROSTATE CANCER CANADA RELEASES NEW RECOMMENDATIONS Lowering the age of baseline testing for prostate cancer Today we released new recommendations to empower Canadian males to take a more active role in monitoring their number one cancer risk: prostate cancer. A recent nationwide poll showed that while 87% of Canadian men aged 35+ fear prostate cancer, less than half anticipate being tested in the next 12 months – even though early diagnosis can increase the odds of survival. Read about it.

PCC Releases New Recommmendations on PSA Testing Read More »

Fla. seaweed may help fight cancer, inflammations

A new defense against prostate cancer, the most common cancer in men in the United States, may come from a seaweed found off the coast of Florida. University of Florida pharmacy researchers have screened various seaweeds with cancer-preventive potential and identified one that shows particular promise. They isolated specific compounds in this common green alga, known as sea lettuce, and undertook studies to understand exactly how they work. Their findings, published Sept. 4 in Cancer Prevention Research, show how the species may protect multiple organs from disease and may be particularly effective in preventing prostate cancer. Read the article.

Fla. seaweed may help fight cancer, inflammations Read More »

VIDEO: Dr. Robert Hamilton, “Hormones, hormone therapy and prostate cancer”

July 2013 Scotiabank Awareness Night “Hormones, hormone therapy and prostate cancer”       Dr. Robert J Hamilton MD, MPH, FRCSC  Surgical Oncologist, The Princess Margaret University Health Network  Assistant Professor, Dept. of Surgery (Urology), University of Toronto Testosterone and related hormones that together we call “androgens” play a role in every aspect of prostate cancer…from reducing chances of being diagnosed with prostate cancer, reducing progression of low risk prostate cancer, as an additive to radiation therapy, to suppressing growth in patients with advanced cancers. Dr. Hamilton presents the role of androgens and hormone therapy across the landscape of prostate

VIDEO: Dr. Robert Hamilton, “Hormones, hormone therapy and prostate cancer” Read More »

Scroll to Top